These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24394498)

  • 1. The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs.
    Rutnam ZJ; Du WW; Yang W; Yang X; Yang BB
    Nat Commun; 2014; 5():2914. PubMed ID: 24394498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TUSC2P suppresses the tumor function of esophageal squamous cell carcinoma by regulating TUSC2 expression and correlates with disease prognosis.
    Liu F; Gong R; He B; Chen F; Hu Z
    BMC Cancer; 2018 Sep; 18(1):894. PubMed ID: 30219035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-663 facilitates the growth, migration and invasion of ovarian cancer cell by inhibiting TUSC2.
    Xie HH; Huan WT; Han JQ; Ren WR; Yang LH
    Biol Res; 2019 Apr; 52(1):18. PubMed ID: 30944041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-632 Promotes Laryngeal Carcinoma Cell Proliferation, Migration, and Invasion Through Negative Regulation of GSK3β.
    Zhou ZX; Zhang ZP; Tao ZZ; Tan TZ
    Oncol Res; 2020 Feb; 28(1):21-31. PubMed ID: 29562960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression.
    Nama S; Muhuri M; Di Pascale F; Quah S; Aswad L; Fullwood M; Sampath P
    Sci Rep; 2019 Sep; 9(1):12718. PubMed ID: 31481748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.
    Yasukawa K; Liew LC; Hagiwara K; Hironaka-Mitsuhashi A; Qin XY; Furutani Y; Tanaka Y; Nakagama H; Kojima S; Kato T; Ochiya T; Gailhouste L
    Cancer Sci; 2020 Mar; 111(3):869-880. PubMed ID: 31883160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.
    Sun KX; Chen Y; Chen S; Liu BL; Feng MX; Zong ZH; Zhao Y
    Oncotarget; 2016 Feb; 7(8):9236-49. PubMed ID: 26843615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
    Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E
    Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein.
    Mariniello RM; Orlandella FM; Stefano AE; Iervolino PLC; Smaldone G; Luciano N; Cervone N; Munciguerra F; Esposito S; Mirabelli P; Salvatore G
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.
    He H; Liao X; Yang Q; Liu Y; Peng Y; Zhong H; Yang J; Zhang H; Yu Z; Zuo Y; Guan C; Xu Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818809993. PubMed ID: 30381030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.
    Chen HS; Lu AQ; Yang PY; Liang J; Wei Y; Shang YW; Li Q
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6621-6628. PubMed ID: 31378904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-623 suppresses cell proliferation, migration and invasion through direct inhibition of XRCC5 in breast cancer.
    Li Q; Liu J; Jia Y; Li T; Zhang M
    Aging (Albany NY); 2020 Jun; 12(11):10246-10258. PubMed ID: 32501811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
    Zheng L; Li X; Gu Y; Lv X; Xi T
    Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.
    Xu H; Hu Y; Qiu W
    Biomed Pharmacother; 2017 Mar; 87():405-411. PubMed ID: 28068630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
    Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-142 inhibits the migration and invasion of glioma by targeting Rac1.
    Qin W; Rong X; Dong J; Yu C; Yang J
    Oncol Rep; 2017 Sep; 38(3):1543-1550. PubMed ID: 28714015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FUS1 acts as a tumor-suppressor gene by upregulating miR-197 in human glioblastoma.
    Xin J; Zhang XK; Xin DY; Li XF; Sun DK; Ma YY; Tian LQ
    Oncol Rep; 2015 Aug; 34(2):868-76. PubMed ID: 26081814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.